High Content Screening (HCS) Market – Global Analysis, Trends, and Forecasts to 2024 – ResearchAndMarkets.com
June 18, 2019DUBLIN–(BUSINESS WIRE)–The “High
Content Screening (HCS): Global Market Analysis, Trends, and Forecasts”
report has been added to ResearchAndMarkets.com’s
offering.
The report analyzes the worldwide markets for High Content Screening
(HCS) in US$ Million. This report provides separate comprehensive
analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of
World. Annual estimates and forecasts are provided for the period 2016
through 2024. Also, a five-year historic analysis is provided for these
markets. Market data and analytics are derived from primary and
secondary research.
The Global market is further analyzed by the following Segments:
- Consumables
- Instruments
- Others
The report profiles 71 companies including many key and niche
players such as:
- BD Biosciences (USA)
- BioTek Instruments Inc. (USA)
- EMD Millipore (USA)
- Evotec AG (Germany)
- Essen BioScience (USA)
- GE Healthcare Life Sciences (Sweden)
- Genedata AG (Switzerland)
- IntelliCyt Corporation (USA)
- Molecular Devices, Inc. (USA)
- PerkinElmer, Inc. (USA)
- Thermo Fisher Scientific, Inc. (USA)
- Thorlabs, Inc. (USA)
- TTP LabTech Ltd. (UK)
- Yokogawa Electric Corporation (Japan)
Key Topics Covered:
1. INDUSTRY OVERVIEW
HCS – An Evolving Screening Technology
HCS Market Ripe with Growth Opportunity
Key Growth Drivers
Key Challenges
Market Outlook
Developing Regions Drive Future Growth
HCS Software
A High Growth Market
Equipment Sales Continue to Expand
Competitive Overview
2. MARKET TRENDS AND ISSUES
HCA
Playing an Important Role in Primary Screening
Technology Advancements Drive Market Growth
HCS Instruments for Analysis of 3D Cell Models
Emergence of Academic Sector as the Major User of HCS
Stem Cell Biology
An Emerging Area of Interest
HCS Specific Data Analysis Systems
The Need of the Hour
HCS vs. HTS
Rise in Adoption of HCS Technology in HTS Laboratories
Market Challenges
High Instrumentation Costs Hamper Rapid Growth
3. PRODUCT OVERVIEW
Defining High Content Screening
The Process of High Content Screening
The Process of High Content Screening
Technology Evolution Over the Years
HCS Tools
List of HCS Tools
HCS Imaging
Categories
Instrumentation
Consumables
Software
Services
4. PRODUCT INTRODUCTIONS/INNOVATIONS
Genedata Launches Early Access Program to Deep Learning for High Content
Screening (HCS) Image Analysis
Yokogawa Electric Releases the CellVoyager CV8000
Molecular Devices launches ImageXpress Micro 4 High-Content Imaging
System
5. RECENT INDUSTRY ACTIVITY
Sartorius Acquires Umetrics and Essen BioScience
Evotec Signs Deal with Genedata Screener for Drug Discovery Data
Management
Sartorius Acquires IntelliCyt
AstraZeneca Signs Agreement with IntelliCyt for the Development of High
Throughput Biology Applications
ONO PHARMACEUTICAL Extends Genedata Screener License
6. FOCUS ON SELECT GLOBAL PLAYERS
7. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 71 (including Divisions/Subsidiaries 80)
- The United States (35)
- Japan (3)
-
Europe (37)
- France (6)
- Germany (9)
- The United Kingdom (10)
- Italy (1)
- Spain (1)
- Rest of Europe (10)
- Asia-Pacific (Excluding Japan) (3)
- Middle East (2)
For more information about this report visit https://www.researchandmarkets.com/r/212oxw
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Drug
Discovery